In analogy, we identified MYC enrichment at the identical site in the CDK7 promoter in various ChIP-seq data sets from breast cancer and B-cell malignancies suggesting that both MITF and MYC are able to directly transactivate CDK7 (Fig. 7c). This evidence concerns the gene MITF and breast carcinoma.